Search results
FDA signals potential shift toward interchangeability for all biosimilars | JD Supra
JD Supra· 6 days agoUnder the Biologics Price Competition and Innovation Act (BPCIA), a “biosimilar” product is one that is demonstrated to be “highly similar” to the reference product with “no clinically meaningful ...
Unveiling Centene (CNC)'s Value: Is It Really Priced Right? A Co
Guru Focus· 3 days agoCentene is a leading managed-care organization primarily engaged with government-sponsored healthcare plans such as Medicaid, Medicare, and individual exchanges. With a significant ...